Fournier-Majoie Foundation
Fournier-Majoie Foundation is a non-profit organization established in 2006 and based in Brussels, Belgium. Its primary mission is to identify, support, and guide promising researchers in the oncology sector. The foundation focuses on investing in innovative projects related to biomarkers, diagnostic tools, medical devices, and technology platforms, providing essential financial backing to advance research and development in these critical areas. Through its initiatives, the foundation aims to foster advancements in cancer research and improve outcomes for patients.
4 past transactions
Hephaistos Pharma
Seed Round in 2024
Hephaistos Pharma is a biotechnology company developing an immunotherapy platform aimed at producing advanced oncology treatments. Its platform enhances commercialized antibodies by stimulating the immune system, turning 'cold' tumors into targets for immune response.
Mablink Bioscience
Seed Round in 2021
Mablink Bioscience is a biotechnology company focused on developing a new class of cancer therapies known as Antibody Drug Conjugates (ADCs). The company specializes in designing homogeneous, plasma-stable ADCs that maintain their original pharmacological properties while achieving a high drug-to-antibody ratio (DAR). This innovative approach aims to provide healthcare professionals with enhanced treatment options for cancer patients, ultimately improving therapeutic outcomes.
ATB Therapeutics
Seed Round in 2019
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
ATB Therapeutics
Seed Round in 2018
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.